Sign in to view content

Senolytic Candidate UBX1325 for Diabetic Macular Edema: The BEHOLD Phase 2 and ASPIRE Phase 2b Trials

Dante Joseph Pieramici, MD

Video
Published 2025

Related

A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)
Raj K. Maturi, MD
Annual Meeting Talks
2021
Part 2: Telemedicine for Diabetic Retinopathy Screening
Jose Agustin Martinez, MD
On Demand Cases, Courses, and Papers
2017
Evaluation of Nonperfusion Area and Other Vascular Metrics by Widefield SS-OCTA as Biomarkers of Diabetic Retinopathy Severity
John B. Miller, MD
Annual Meeting Talks
2021

Category: Retinal Vascular Disease

See more